Beyond coronary thrombolysis
Publication
, Journal Article
Becker, RC; Alpert, JS
Published in: Archives of Internal Medicine
1988
In summary, the availability of the thrombolytic agents recombinant tissue plasminogen activator and streptokinase for use in the early treatment of AMI is an important step in the management of a common, often debilitating, and potentially lethal disorder. However, more extensive and complete myocardial salvage than that which can be achieved by reperfusion alone is possible. Clinical trials combining thrombolytic and adjunctive pharmacologic agents offer hope for further advances in the treatment of acute myocardial infarction.
Duke Scholars
Published In
Archives of Internal Medicine
Publication Date
1988
Volume
148
Issue
7
Start / End Page
1503 / 1507
Related Subject Headings
- General & Internal Medicine
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Becker, R. C., & Alpert, J. S. (1988). Beyond coronary thrombolysis. Archives of Internal Medicine, 148(7), 1503–1507.
Becker, R. C., and J. S. Alpert. “Beyond coronary thrombolysis.” Archives of Internal Medicine 148, no. 7 (1988): 1503–7.
Becker RC, Alpert JS. Beyond coronary thrombolysis. Archives of Internal Medicine. 1988;148(7):1503–7.
Becker, R. C., and J. S. Alpert. “Beyond coronary thrombolysis.” Archives of Internal Medicine, vol. 148, no. 7, 1988, pp. 1503–07.
Becker RC, Alpert JS. Beyond coronary thrombolysis. Archives of Internal Medicine. 1988;148(7):1503–1507.
Published In
Archives of Internal Medicine
Publication Date
1988
Volume
148
Issue
7
Start / End Page
1503 / 1507
Related Subject Headings
- General & Internal Medicine
- 11 Medical and Health Sciences